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AbstrACt
Introduction Advance care planning (ACP) is a key 
component of high-quality end-of-life care but is underused. 
Interventions based on models of behaviour change may 
fill an important gap in available programmes to increase 
ACP engagement. Such interventions are designed for broad 
outreach and flexibility in delivery. The purpose of the Sharing 
and Talking about My Preferences study is to examine the 
efficacy of three behaviour change approaches to increasing 
ACP engagement through two related randomised controlled 
trials being conducted in different settings (Veterans Affairs 
(VA) medical centre and community).
Methods and analysis Eligible participants are 55 years or 
older. Participants in the community are being recruited in 
person in primary care and specialty outpatient practices and 
senior living sites, and participants in the VA are recruited by 
telephone. In the community, randomisation is at the level 
of the practice or site, with all persons at a given practice/
site receiving either computer-tailored feedback with a 
behaviour stage-matched brochure (computer-tailored 
intervention (CTI)) or usual care. At the VA, randomisation is 
at the level of the participant and is stratified by the number 
of ACP behaviours completed at baseline. Participants 
are randomised to one of four groups: CTI, motivational 
interviewing, motivational enhancement therapy or usual 
care. The primary outcome is completion of four key ACP 
behaviours: identification of a surrogate decision maker, 
communication about goals, completing advance directives 
and ensuring documents are in the medical record. Analysis 
will be conducted using mixed effects models, taking into 
account the clustered randomisation for the community study.
Ethics and randomisation The studies have been approved 
by the appropriate Institutional Review Boards and are being 
overseen by a Safety Monitoring Committee. The results of 
these studies will be disseminated to academic audiences 
and leadership in in the community and VA sites.
trial registration numbers NCT03137459 and 
NCT03103828.
IntroduCtIon 
The Institute of Medicine (IOM) report, 
‘Dying in America: Improving Quality and 
Honoring Individual Preferences near the 
End of Life’ devotes an entire chapter to 
advance care planning (ACP), the process 
by which patients can plan for the care they 
will receive if they become incapable of 
participating in medical decision making.1 
The report endorses the promise of ACP to 
provide ‘a measure of control over the final 
phase of life’ and to ensure that ‘patients’ 
wishes are known and respected to the 
extent possible’. ACP is also associated with 
improved caregiver outcomes.2 3 However, 
as outlined in the IOM report chapter, ACP 
remains underused. A recent systematic 
review concluded that only approximately 
one-third of adults in the USA has completed 
advance directives (ADs).4 Moreover, ADs 
alone are not sufficient in the absence of 
efforts to promote communication.5 
Several intervention approaches have 
demonstrated efficacy in increasing engage-
ment in ACP. Respecting Choices, consisting 
of facilitated discussions lasting between 60 
min and 90 min between patients and their 
surrogates, increased surrogates’ knowl-
edge of patients’ preferences and reduced 
strengths and limitations of this study
 ► The intervention is based on a comprehensive model 
of advance care planning (ACP) that focuses on en-
hancing engagement and improving communication 
among patients, their surrogates and their providers.
 ► The behavioural health approach to ACP provides 
a framework for practical interventions that can be 
implemented in a wide variety of settings.
 ► The interventions have been developed in English 
only, and the study therefore excludes individuals 
whose primary language is other than English.
 ► The study is being conducted in a single geo-
graphic region and therefore may have limited 
generalisability.
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caregiver stress.6 7 The PREPARE website, a self-adminis-
tered tool providing step-by-step processes for ACP supple-
mented with video stories and modelling of behaviours, 
increased ACP documentation.8 Additional approaches 
may be necessary to bridge the gap between intensive 
clinician-led and self-administered tools for ACP engage-
ment. For example, efforts to replicate and disseminate 
the Respecting Choices programme in a large metropol-
itan area required ‘concerted and sustained leadership’, 
a prolonged planning phase and the subsidising of sala-
ries.9 This experience suggests that intensive programmes 
are best targeted to selected patients at high risk of facing 
difficult treatment choices. The IOM report supports 
such targeting, suggesting a lifespan approach to ACP, 
beginning early with broad considerations of wishes 
that become more clinical and detailed over time. This 
lifespan strategy is congruent with our approach, which 
is designed to promote widespread dissemination of 
material that engages individuals in midlife and works to 
give them the tools to help them reconsider their wishes 
over time as health challenges become clearer. While 
the PREPARE website provides a thorough introduction 
to ACP, over 50% of participants had no access to the 
internet, and the website was viewed in research offices,8 
suggesting that web-based materials may have limited 
outreach.
The Sharing and Talking about My Prefer-
ences (STAMP) study was designed to address gaps in 
the existing programmes for promoting participation in 
ACP. The STAMP interventions are based on the concep-
tual model of ACP considered as a set of inter-related 
health behaviours.10 Prior research has demonstrated 
that participants have variable readiness to engage in 
ACP behaviours10 and that this readiness can be repre-
sented and explained by constructs of the Transtheoret-
ical Model (TTM), including stages of change, decisional 
balance (the pros and cons of behaviour change) and 
processes of change.11 Readiness is also explained by a 
construct of values/beliefs. Unlike the pros and cons, 
which are factually verifiable, values and beliefs consist of 
common misperceptions about ACP and religious values 
that can function as barriers to ACP.11
STAMP evaluates three behaviour change approaches 
to promoting ACP engagement. The first is the use of 
individualised feedback reports with stage-matched 
brochures.12 The second is telephone-delivered motiva-
tional interviewing (MI), and the third is telephone-de-
livered motivational enhancement therapy (MET), a 
combination of written feedback and MI. The health 
behaviours consist of: (A) identifying a trusted indi-
vidual to act as a surrogate decision maker or healthcare 
agent; (B) communicating with this person about goals, 
preferences and values; (C) completing ADs (formal 
assignment of healthcare agent and living will); and (D) 
ensuring both that the physician is aware of documents 
and that documents are in the medical record. STAMP 
consists of two related randomised controlled trials 
(RCTs). The hypothesis is that individuals receiving each 
of the behaviour change approaches will be more likely 
than individuals receiving usual care to complete all of 
the health behaviours.
MEthods And AnAlysIs
study overview
STAMP consists of two related RCTs, with shared inclusion 
and exclusion criteria for study participation, measures, 
outcomes and analytic approaches but with enrolment 
procedures and interventions adapted for each of the 
two trials. Each RCT will test the efficacy of one or more 
interventions on the proportion of study participants who 
complete participation in ACP compared with usual care. 
One RCT is being conducted within the primary care 
clinics of the Veterans Affairs Connecticut Healthcare 
System (subsequently referred to as the VA study), and 
the second is in community-based primary care practices 
and senior living communities in the greater New Haven 
area (subsequently referred to as the community study). 
Trial registration data are provided in table 1.
Participants, recruitment and enrolment
Inclusion criteria include: age 55 years or older and, for 
participants recruited in the VA study, having a primary 
care clinic visit within the last 12 months. Exclusion criteria 
include: severe hearing or vision loss, moderate-to-severe 
cognitive impairment identified by chart review (VA study 
only), physician diagnosis, Brief Orientation Memory 
Concentration test score >1013 or inability to participate in 
the process of informed consent; primary language other 
than English; active psychiatric illness (current symptoms 
of depression, anxiety, substance abuse or psychosis), 
no regular access to a telephone; no permanent mailing 
address; completion of all four ACP behaviours; or lack of 
physician permission for participation.
Screening, recruitment and enrolment for partici-
pants differs according to study. In the VA study, poten-
tial participants are selected from a list obtained under 
a Health Insurance Portability and Accountability Act 
waiver of all persons age 55 years and older who have had 
a primary care visit within the last year at VA Connecticut. 
This method of identifying participants accomplishes two 
objectives. First, it facilitates oversampling of women and 
minorities to ensure adequate representation in the study 
population. The study is aiming for 25% women and 
40% non-white participants. Second, it allows for all study 
procedures to be done by telephone. Veterans relying on 
public transportation face a significant barrier to access, 
with only 25% living within a 60 min transit time from a 
VA medical facility.14 The ability to identify individuals 
and deliver the intervention by telephone is in keeping 
with the VA’s investment in telehealth to improve access 
to a variety of services.15 Chart screens are performed 
to identify exclusion criteria. Potentially eligible partici-
pants are sent an opt-out letter. If they do not opt out, 
a research assistant calls the participant to explain the 
study and completes the screening for eligibility. If the 
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participant is eligible and interested in participation, a 
process of verbal assent is obtained. Participants who are 
randomised to MI or MET are asked if they have a surro-
gate they would like to include in their MI/MET session. 
If they do, they are asked to provide the contact infor-
mation for the surrogate, who must then provide verbal 
assent prior to inclusion in the session. All identifiable 
data are stored separately from study records, which are 
identified by code number, in access-restricted database 
files behind institutional firewalls. Printed records are 
kept in locked offices.
Recruitment in the community study is designed to 
encourage ACP as a part of routine healthcare. In commu-
nity practices, the list of patients scheduled for either well 
patient or routine follow-up visits is reviewed prior to 
each clinic session to identify potentially eligible partic-
ipants. These individuals are given an information sheet 
to read prior to the encounter. The clinician confirms 
patient interest in the study, and willing individuals meet 
with a research assistant at the end of the encounter to 
complete a process of written informed consent. In senior 
living communities, recruitment takes place both in the 
on-site medical clinics as described above and among 
the community as a whole. For the latter, the study is 
introduced in a talk given by the principal investigator, 
followed by the opportunity for volunteers to sign up 
for times to meet with the research assistant to complete 
written informed consent.
Intervention and control conditions
Similar to recruitment procedures, the intervention arms 
are tailored to take advantage of the opportunities offered 
by the different study settings. The availability of health 
psychologists and MI training at the VA supported the 
strategy of developing MI interventions to promote ACP 
engagement in addition to a computer-tailored interven-
tion (CTI) that generates printed feedback. Therefore, 
in the VA study, there are four arms: CTI, MI, MET and 
control. In the community, there are two arms: CTI and 
control. All arms consist of contact at baseline, 2 months 
Table 1 Trial registration data
Category STAMP (Community) STAMP (VA)
Primary registry and trial identifying 
number
ClinicalTrials.gov
NCT03103828
ClinicalTrials.gov
NCT03137459
Date of registration in primary 
registry
27 April 2017 31 March 2017
Source(s) of monetary or material 
support
NIH/NINR
NIH/NIA
VA HSR&D
Primary sponsor NIH/NINR VA HSR&D
Secondary sponsor None None
Contact for public queries Lynne Iannone, MS: lynne.iannone@yale.edu
Contact for scientific queries Terri Fried, MD: terri.fried@yale.edu
Public title STAMP: Sharing and Talking about My Preferences
Scientific title STAMP: Sharing and Talking about My Preferences
Countries of recruitment USA USA
Health condition(s) or problem(s) 
studied
Advance care planning (ACP)
Intervention(s) Active comparator: TTM-based CTI; no 
intervention: usual care.
Active comparators: TTM-based CTI, MI, 
MET; no intervention: usual care.
Key inclusion and exclusion criteria Inclusion: age 55 years and older and belonging to healthcare system or residential 
community. Exclusion: severe hearing impairment, severe visual, moderate to severe 
cognitive impairment, primary language other than English, active psychiatric illness, 
completion of all four key ACP behaviours.
Study type Interventional; allocation: randomised; intervention model: parallel assignment; masking: 
single masking (outcomes assessor); primary purpose: health services research.
Date of first enrolment July 2017 October 2017
Target sample size 1000 484
Recruitment status Recruiting
Primary outcome(s) Completion of four key ACP behaviours
Key secondary outcomes Stage of change for each of the four key ACP behaviours
CTI, computer tailored intervention; HSR&D, Health Services Research and Delivery; MET, motivational enhancement therapy; MI, motivational 
interviewing; NIA, National Institute on Aging; NIH, National Institutes of Health; NINR, National Institute of Nursing Research; TTM, 
Transtheoretical Model; VA, Veterans Affairs.
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and 4 months with delivery of the intervention according 
to assignment. There is a contact at 6 months for final 
assessment.
Computer-tailored intervention
The development of the CTI has been previously 
described.12 Briefly, it is an expert system (a software 
system consisting of an assessment battery, normative 
data to make comparisons, decision rules for delivering 
feedback and feedback components) based on the TTM. 
TTM intervention principles include respecting and 
reflecting individuals’ stages of change and their progress 
over time on each construct in individualised feedback 
reports. Such reports have been found to be effective 
across a wide range of other health behaviours.16 The 
system assesses key constructs of the TTM, including 
stage of change (readiness to participate in each of the 
ACP behaviours), decisional balance, values/beliefs and 
processes of change. The original system consisted of feed-
back paragraphs developed for each stage of the four ACP 
behaviours and for decisional balance, which are pulled 
into a templated cross-sectional, or ‘normative’, report. 
For this study, the system was further developed in order 
to give feedback based on simultaneous consideration of 
stage for all four behaviours (referred to as stage pattern) 
as well as to give longitudinal feedback by comparing stage 
at follow-up to stage at baseline (‘ipsative’ reporting). 
Each feedback report consists of: (1) introduction to ACP 
(common across reports); (2) figure illustrating stage of 
change for each behaviour (normative) and changes in 
stage at follow-up (ipsative) (see figure 1); (3) brief stage 
pattern-tailored feedback; (4) feedback for up to three 
endorsed values/beliefs items; (5) decisional balance by 
stage pattern feedback; (6) processes/strategies/efficacy 
or ‘next steps’ stage pattern-tailored feedback; and (7) 
Figure 1 Example of figure included in follow-up feedback report illustrating change in readiness over time for the ACP 
behaviours. ACP, advance care planning.
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summary. For participants in the earliest stages of change 
for multiple behaviours, the report provides brief ‘next 
steps’ focused on activities to help promote favourable 
attitudes towards ACP. For participants in later stages, 
the report provides suggestions for how the participant 
can go about engaging in the behaviour. The ‘next steps’ 
section also informs participants how completing one 
ACP behaviour can help in the completion of others.
The feedback reports make reference to one of two 
stage-matched brochures. Each of these brochures 
provides additional details of ACP. The first brochure, 
provided to participants who have not yet completed 
any of the ACP behaviours, provides additional infor-
mation promoting the reasons for engaging in ACP and 
addressing potential barriers. It also contains two stories 
describing families who did and did not engage in ACP. 
The second brochure, provided to participants who have 
completed at least one ACP behaviour, also contains 
additional information about how to engage in each. In 
addition, this brochure contains either the VA or state 
of Connecticut Advance Directives Form. Finally, partic-
ipants receive a fourfold pamphlet designed to be given 
to potential surrogate decision makers in order to explain 
their role in ACP.
For participants enrolled in the VA, the assessment 
occurs by telephone, and the feedback report, brochure, 
and pamphlet are mailed. For participants enrolled in 
the community, the initial assessment is done in person 
in the clinician office or private space in the senior living 
community, and the report is printed using a portable 
printer. If the participant does not have sufficient time 
after his or her appointment but has provided informed 
consent, the assessment is done by telephone at a later 
time. All follow-up assessments are done by telephone, 
with reports mailed to participants.
Motivational interviewing
The development of the MI protocol has been previously 
described.17 MI sessions are conducted by health psychol-
ogists and social workers who have received training by 
Dr Martino, a member of the research team and of the 
Motivational Interviewing Network of Trainers, who is 
an expert in training clinicians in the conduct of MI for 
clinical trials.18–20 The training consisted of a 2-day expe-
riential workshop and STAMP MI/MET manual review, 
followed by supervised practice cases, incorporating 
fidelity rating-based feedback and coaching based on the 
review of audio recorded telephone sessions using the 
Independent Tape Rater Scale.21 Dr Martino reviewed 
and rated all practice cases for initial certification. Initial 
certification was defined as at least adequate or average 
adherence and competence ratings on three consecu-
tive practice sessions. If a clinician’s performance later 
drifts below the initial certification level during the trial, 
then Dr Martino will provide additional supervision and 
training and assign another practice case if necessary. The 
MI intervention consists of four steps: (1) elicitation and 
clarification of patient’s understanding of and current 
engagement in ACP; (2) building motivation for ACP; 
(3) developing a change plan; and (4) summarising the 
overall discussion. The first step involves understanding 
in what ways the patient thinks ACP is important and 
the patient’s knowledge of the four key ACP behaviours. 
Consistent with MI, the Elicit-Provide-Elicit approach is 
used to deliver ACP. This approach involves inviting the 
patient to share his or her knowledge, asking the patient 
permission to provide additional information, and then 
eliciting the patient’s reaction to this new information. 
The second step consists of four activities that are used 
as needed. The first activity is an enhanced discussion of 
reasons to engage in ACP, with attention paid to devel-
oping the discrepancies between the most important 
reasons for engagement and lack of ACP participation. 
The second is addressing beliefs that serve as barriers to 
ACP. The third is an exercise to help patients clarify their 
values regarding quality versus quantity of life. Under-
standing how patients view this trade-off is central to deci-
sion making about potentially life-sustaining treatment22 
and is included in a number of ACP tools23 24 as well as in 
the brochure provided with CTI. The fourth activity is a 
discussion of experiences that could help ACP engage-
ment. If the participant has a surrogate who agrees to be 
part of the MI, the surrogate’s perspectives are elicited in 
each of these steps. In pilot testing, sessions lasted a mean 
(SD) of 34.9 (6.5) minutes.
Motivational enhancement therapy
In the MET arm, participants are provided the CTI 
TTM-based feedback materials, and then engage in an 
MI interview as described previously, with the addition of 
review of the materials with the clinician. Each compo-
nent of the interview makes mention as appropriate 
to specific sections of the stage-matched brochures to 
address knowledge gaps and provide more information 
about reasons to engage in ACP and addressing ACP 
barriers. In an additional section of the interview specific 
to MET, the clinician reviews the personalised feedback 
report with the participant to facilitate the development 
of a change plan.
Control
Participants in the control arm receive assessments at 
baseline, 2 months and 4 months but do not receive any 
additional information about ACP, other than that poten-
tially provided in usual care. In order to minimise the 
effect of asking about ACP behaviours on participants’ 
engagement in these behaviours, the control assessments 
conclude with questions about readiness to engage in and 
pros and cons of physical activity.
randomisation
Randomisation in the community trial is at the level of 
the practice/senior living community in order to avoid 
contamination. Contamination could occur if patients 
assigned to the intervention increased their clini-
cians’ awareness of ACP, and then clinicians changed 
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their behaviours towards other participants potentially 
assigned to the control group. Therefore, randomisation 
occurs within matched pairs of sites, instead of at the 
individual level. Sites are matched according to available 
data regarding characteristics most likely to be associated 
with ACP participation. For clinical sites, this includes 
proportion of patients: age 55 years and older, non-white 
and with Medicaid. For senior living communities, this 
includes type of community (eg, continuing care retire-
ment community) and, if applicable, type of contract 
(eg, life care and fee-for-service). After matching, sites 
are randomised by means of computer-based random 
number generator.
Because participants at the VA belong to a very large 
panel of providers, each of whom would have only a 
small number of patients in the study, randomisation is 
at the level of the patient. Number of ACP behaviours 
completed at baseline may be the single variable most 
highly associated with the likelihood of full ACP engage-
ment, since engagement is cross-sectionally related to 
attitudes, beliefs and processes related to ACP11 and to 
a number of sociodemographic characteristics25 and life 
experiences.26 Therefore, in order to ensure balanced 
representation of number of ACP activities completed 
at baseline across the four study arms, participants are 
assigned using stratified permuted block randomisation 
with a block length of eight via a customised computer 
program that provides the assignment at the time of 
randomisation.
blinding
Participants are not blinded to their assignment. 
Research assistants are not blinded to participant assign-
ment at interim time points since the assessment, as 
described below, differs slightly according to the assign-
ment. However, blinded research assistants ascertain the 
primary study outcome at the 6-month assessment.
Measures
The primary outcome is having completed, or being in the 
action/maintenance stage as specified in the TTM, for all 
of the four key ACP behaviours at 6 months. The designa-
tion of action and maintenance was originally designed 
for behaviours that required ongoing effort, such as 
smoking cessation and exercise, and refer to how long 
ago the behaviour was initiated. While there are activi-
ties that an individual can and should be doing during 
the maintenance phase of ACP, such as reviewing and 
updating documents, the focus for this study was on initial 
engagement in ACP. Therefore, these two stages were 
combined. The secondary outcomes are the stage of change 
for each of the behaviours. The stages of change prior to 
action/maintenance are: precontemplation, or not ready 
to take action within the next 6 months; contemplation, 
or thinking about taking action over the next 6 months; 
and preparation, or planning on taking action in the next 
30 days. These variables are measured at each assessment: 
baseline, 2 months, 4 months and 6 months.
Sociodemographic, health and psychosocial status vari-
ables are assessed to describe the study population, test for 
the adequacy of randomisation and use as covariates. The 
sociodemographic status variables include: age, gender, 
race/ethnicity, level of education, income, marital status, 
housing type and living alone or with others. The health 
status variables include: self-rated health,27 self-rated 
quality of life and variables included in a validated prog-
nostic index for 4-year mortality: current tobacco use, 
chronic conditions and functional status.28 The psychoso-
cial status variables include: depression, measured using 
the Patient Health Questionnaire - 2 (PHQ-2),29 and 
religion, measured using the Duke University Religion 
Index,30 and experience with surrogate medical decision 
making.26 These descriptive variables are measured at 
baseline only.
Additional constructs of the TTM are being assessed 
both as input for the expert system and as variables to be 
used in TTM-based models of ACP as behaviour change. 
These constructs are posited to be mediation variables 
in the pathway of behaviour change and include deci-
sional balance, values/beliefs, confidence and processes 
of change.11 ACP knowledge is also assessed as a poten-
tial mediator.25 These variables are measured at each 
assessment.
The final 6-month assessment includes additional eval-
uation measures, asking participants how much partici-
pation in the study: increased their own interest in ACP, 
the interest of a significant other in ACP and was respon-
sible for their own and/or a significant other’s movement 
forward with ACP.
In order to minimise missing data, a shortened form 
of the 6-month assessment is available to those partici-
pants who do not want to complete a full assessment but 
are willing to answer an abbreviated set of items. This 
outcome assessment consists only of stage of change for 
the four ACP behaviours.
Participants recruited from community settings complete 
the baseline assessment as administered by a research assis-
tant in person, unless they cannot stay after the appoint-
ment, in which case the assessment is completed by phone. 
They have the choice to complete follow-up assessments 
either by telephone or through self-administration. Both 
participants and research assistants access the assess-
ment developed through the customisation of TTMX, 
proprietary behaviour change software licenced through 
Pro-Change Behavior Systems, Inc. The program is 
designed to support high-quality data collection by having 
respondents click on radio buttons next to responses to 
minimise data entry errors and not allowing respondents 
to leave a page until all questions are answered. Assess-
ments can be completed up to 7 days prior to or 30 days 
following the target date. Participants recruited from the 
VA complete all assessments by telephone.
Analytic plan
The analysis for the community study is based on the 
study design of two groups (intervention and control) 
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assessed on four occasions (baseline, 2, 4 and 6 months) 
with sites nested in groups based on cluster randomi-
sation of matched pairs of sites. Baseline analyses will 
include examination of group differences to evaluate 
the success of the matched-pairs randomisation proce-
dure and examination of potential covariates to reduce 
the expected within-groups dependency resulting from 
cluster randomisation.
The primary analysis will address the hypothesis that the 
proportion of participants in action/maintenance for the 
four ACP behaviours will be higher in the intervention 
group than in the control group at the 6-month assess-
ment. Several analytical approaches are available within 
a more general framework of random effects modelling 
incorporating both time and site level effects in addition 
to potentially important covariates. The basic analytical 
approach will employ the generalised estimating equa-
tion (GEE) method to analyse intervention main effects 
and interaction (additive) effects.31 Analytic models will 
include interaction terms for time point and site. This will 
permit an examination of the effect of the intervention 
at the primary endpoint of 6 months and at the interme-
diate time points of 2 and 4 months.
The analysis for the VA study is based on the study 
design of four groups assessed on four occasions. The 
primary analysis for this study will address the hypoth-
esis that the proportions of participants in action/main-
tenance for the four ACP behaviours will be higher in 
each intervention group than in the control group at the 
6-month assessment. A logistic model that contains inter-
vention group (CTI, MET, CTI+MET, with reference=con-
trol) as a categorical predictor will be used to analyse this 
outcome. The model will also control for the stratification 
variable (number of ACP activities completed at base-
line) and for any factors found to be unbalanced across 
groups. Prespecified subgroup analyses will be conducted 
by using the same logistic modelling approach within 
each of the strata. Although the study is not powered to 
find significant differences between intervention arms or 
within strata, the study will provide preliminary data for 
future studies regarding the effect sizes for each interven-
tion arm and potential differences in effectiveness within 
subgroups.
Analytic approaches for secondary outcomes will follow 
the same plan in both studies and be similar to those 
employed for the primary outcome variable. Both cate-
gorical and continuous secondary outcomes will be exam-
ined, including specific behavioural and intermediate 
outcome measures, such as the number of ACP behaviours 
changed and ACP attitudes. For continuous measures, 
multivariate analysis of variance, structural equation 
modelling, latent growth curve modelling and GEE tech-
niques will be used. For categorical measures, latent tran-
sition analysis, logistic regression and GEE techniques will 
be used. For skewed frequency/count data, appropriate 
data transformation or Poisson regression approaches 
can be employed. Secondary analyses will also examine 
the nature of behaviour change within and across groups 
over time within the framework of multilevel structural 
equation modelling, including latent growth curve model-
ling, mediation modelling, cross-lagged panel designs 
and model invariance testing.32–36 These analyses will 
examine the relationships between intervention, medi-
ator and moderator process measures. These analyses will 
provide considerable insight into how the interventions 
may be effecting change and will be especially helpful for 
continued development and refinement of the interven-
tion. Mediation analysis in the control group will focus 
on how TTM constructs predict longitudinal adoption 
of ACP. Mediation analysis in the intervention group(s) 
will focus on how the TTM constructs and other socio-
demographic factors compare as mediators of effective 
interventions. Because these modelling approaches can 
be complex, they will proceed in stepwise fashion system-
atically adding constructs and time points to more basic 
models to ensure model convergence. Models are built 
from the simplest to the most complex that the data and 
theory can support, using robust estimation methods and 
bias-corrected bootstrapping strategies for final model 
estimation and hypothesis testing.
sample size
The sample size calculation for the community-based 
study was complicated by the use of practice site as the 
unit of treatment assignment and analysis, which intro-
duces an unknown degree of dependency into the data. 
This dependency, or intraclass correlation (ICC), was 
conservatively assumed to be ICC=0.05 based on existing 
cross-sectional data,25 without covariate adjustment.
This cross-sectional data also provided an estimate of 
the prevalence of the primary outcome of between 4% 
and 8%.25 We conservatively estimated that the prev-
alence of this outcome in the control group which, 
because of our exclusion criteria, will be 0% at baseline, 
will be 5% at the 6-month assessment. The sample size 
is based on the ability to detect an absolute increase of 
10% for the primary outcome in the treatment group 
over the control group, consistent with effect sizes in 
previous TTM-tailored interventions and a judgement 
regarding a minimum clinically significant effect size. 
Sample size calculations assumed one-tailed significance 
testing at alpha=0.05 and were based on a one-way analysis 
of variance for proportions with arcsine transformation 
and nested random effects for sites to accommodate the 
cluster randomised design.37 Based on an enrolment of a 
minimum of 16 sites for the study (eight matched pairs), 
to achieve power of 0.80 for the primary outcome, a final 
sample size of 50 individuals per site is needed, resulting 
in a final study sample size of 800. Assuming 20% loss to 
follow-up, we estimate that a baseline sample size of 1000 
for the community sample is required.
In the VA study, using the same estimates of 5% prev-
alence of the primary outcome in the control group, a 
sample size of 110 per group is required to detect an abso-
lute increase of 10% for the primary outcome in each of 
the intervention groups to achieve a power of 0.80 with an 
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alpha=0.05. Based on prior experience within VA samples, 
a lower 10% loss to follow-up was assumed, resulting in a 
baseline sample size of 121 per group, for a total of 484.
Patient and public involvement
The ACP behaviours that are both the targets of interven-
tion and the outcome measures for the STAMP studies 
were developed based on the input of older persons, 
their surrogate decision makers and bereaved care-
givers obtained during focus groups10 and individual 
interviews.38 The assessment and printed intervention 
materials were pilot tested and modified in response 
to participant feedback, both about the content of the 
feedback and also regarding the length and burden of 
the assessment items.12 All procedures being used in the 
protocols were pilot tested in two practices, and modi-
fications were made in response to feedback both from 
patients and physicians. There are no plans to dissemi-
nate the study results to participants.
EthICs And dIssEMInAtIon
Ethics
The study is being monitored with the use of a Safety 
Monitoring Committee. Members of this committee, with 
expertise in clinical geriatrics and study conduct, have 
reviewed and approved all study protocols and materials. 
Quarterly meetings occur to review any adverse events.
dissemination
The results of the study will be presented to academic 
audiences through presentations at national meetings 
and publication in peer-reviewed journals. The principal 
investigator has partnered with leadership in both the 
community and VA settings, with ongoing discussion of 
how the STAMP interventions can be implemented, if 
shown to be efficacious.
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